(ANSA) - BELGRADE, MAR 9 - LEK d.d., a member of the Sandoz
Group, plans to invest an estimated 400 million euros in
Lendava, Slovenia, making it one of the largest foreign direct
investments in Slovenia's history and the largest single
investment in Lek's history, according to a statement released
by the Slovenian government today. The investment will be used
to establish a high-tech manufacturing facility for biosimilar
drugs. The Slovenian government added that Lek is expected to
begin construction this year, with full operation of the
production centre with low environmental impacts scheduled for
the end of 2026.
"Slovenia today is a politically stable, orderly and attractive
country in all respects. Our economic environment is resilient
and predictable, we have a skilled and highly educated
workforce, an excellent geo-strategic location and a
well-developed infrastructure," Slovenia prime minister Robert
Golob commented. (ANSA).
Leggi l'articolo completo su ANSA.it
Slovenia: 400 mn for high-tech centre for biosimilars
One of the largest investments in the country